4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-022434
Chief Financial Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…